The 1H NMR profile of healthy dog cerebrospinal fluid

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Musteata, Mihai ^a   Nicolescu, Alina ^b,c   Solcan, Gheorghe ^a   Deleanu, Calin ^b,c  

^a UNIVERSITY OF AGRICULTURAL SCIENCES AND VETERINARY MEDICINE   (Romania)

^b PETRU PONI INSTITUTE OF MACROMOLECULAR CHEMISTRY   (Romania)

^c INSTITUTE OF ORGANIC CHEMISTRY   (Romania)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; CEREBROSPINAL FLUID; DOG; FEMALE; HEALTH; HUMAN; MALE; METABOLOME; PROTON NUCLEAR MAGNETIC RESONANCE;

ANIMALS; DOGS; FEMALE; HEALTH; HUMANS; MALE; METABOLOME; PROTON MAGNETIC RESONANCE SPECTROSCOPY;

EID: 84893516508     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0081192     Document Type: Article

References (62)

1. Oliver SG (1997) Yeast as a navigational aid in genome analysis. 1996 Kathleen Barton-Wright Memorial Lecture. Microbiology 143 (5): 1483-1487. doi:10.1099/00221287-143-5-1483.
2. Nicholson JK, Lindon JC, Holmes E (1999) 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 29: 1181-1189. doi:10.1080/004982599238047. PubMed: 10598751.
3. Lindon JC, Holmes E, Nicholson JK (2003) So what's the deal with metabonomics? Anal Chem 75: 384A-391A. PubMed: 14632032. (Pubitemid 37082218)
4. Wishart DS, Lewis MJ, Morrissey JA, Flegel MD, Jeroncic K et al. (2008) The human cerebrospinal fluid metabolome. J Chromatogr B Analyt Technol Biomed Life Sci 871: 164-173. doi:10.1016/j.jchromb.2008.05.001. PubMed: 18502700.
5. Mishur RJ, Rea SL (2012) Applications of mass spectrometry to metabolomics and metabonomics: detection of biomarkers of aging and of age-related diseases. Mass Spectrom Rev 31: 70-95. doi:10.1002/mas.20338. PubMed: 21538458.
6. Jukarainen NM, Korhonen SP, Laakso MP, Korolainen MA, Niemitz M et al. (2008) Quantification of H-1 NMR spectra of human cerebrospinal fluid: a protocol based on constrained total-line-shape analysis. Metabolomics 4: 150-160. doi:10.1007/s11306-008-0106-6.
7. Trygg J, Holmes E, Lundstedt T (2007) Chemometrics in metabonomics. J Proteome Res 6: 469-479. doi:10.1021/pr060594q. PubMed: 17269704. (Pubitemid 46340151)
8. Lenz EM, Wilson ID (2007) Analytical strategies in metabonomics. J Proteome Res 6: 443-458. doi:10.1021/pr0605217. PubMed: 17269702. (Pubitemid 46340149)
9. Di Terlizzi R, Platt S (2006) The function, composition and analysis of cerebrospinal fluid in companion animals: Part I - Function and composition. Vet J 172: 422-431. doi:10.1016/j.tvjl.2005.07.021. PubMed: 16154365. (Pubitemid 44575920)
10. Bechter K (2011) The peripheral cerebrospinal fluid outflow pathway - physiology and pathophysiology of CSF recirculation: A review and hypothesis. Neurol Psychiatry Brain Res 17: 51-66. doi:10.1016/j.npbr.2011.06.003.
11. Oreskovic D, Klarica M (2010) The formation of cerebrospinal fluid: Nearly a hundred years of interpretations and misinterpretations. Brain. Res Rev 64: 241-262. doi:10.1016/j.brainresrev.2010.04.006.
12. Holmes E, Tsang TM, Tabrizi SJ (2006) The application of NMR-based metabonomics in neurological disorders. NeuroRx 3: 358-372. doi:10.1016/j.nurx. 2006.05.004. PubMed: 16815219. (Pubitemid 43964900)
13. Nagashima H, Morio Y, Meshitsuka S, Yamane K, Nanjo Y et al. (2010) High-resolution nuclear magnetic resonance spectroscopic study of metabolites in the cerebrospinal fluid of patients with cervical myelopathy and lumbar radiculopathy. Eur Spine J 19: 1363-1368. doi:10.1007/s00586-010-1453-3. PubMed: 20490871.
14. Wevers RA, Engelke U, Wendel U, de Jong JGN, Gabreëls FJM et al. (1995) Standardized Method for High-Resolution H-1-Nmr of Cerebrospinal-Fluid. Clin Chem 41: 744-751. PubMed: 7729054.
15. Mandal R, Guo AC, Chaudhary KK, Liu P, Yallou FS et al. (2012) Multiplatform characterization of the human cerebrospinal fluid metabolome: a comprehensive and quantitative update. Genome Med 4: 38. doi:10.1186/gm337. PubMed: 22546835.
16. Dunne VG, Bhattachayya S, Besser M, Rae C, Griffin JL (2005) Metabolites from cerebrospinal fluid in aneurysmal subarachnoid haemorrhage correlate with vasospasm and clinical outcome: a patternrecognition 1H NMR study. NMR Biomed 18: 24-33. doi:10.1002/nbm.918. PubMed: 15455468. (Pubitemid 40347540)
17. Koschorek F, Offermann W, Stelten J, Braunsdorf WE, Steller U et al. (1993) High-resolution 1H NMR spectroscopy of cerebrospinal fluid in spinal diseases. Neurosurg Rev 16: 307-315. doi:10.1007/BF00383842. PubMed: 8127445. (Pubitemid 24028685)
18. Sinclair AJ, Viant MR, Ball AK, Burdon MA, Walker EA et al. (2010) NMR-based metabolomic analysis of cerebrospinal fluid and serum in neurological diseases - a diagnostic tool? NMR Biomed 23: 123-132. PubMed: 19691132.
19. Tarnaris A, Watkins LD, Kitchen ND (2006) Biomarkers in chronic adult hydrocephalus. Cerebrospinal Fluid Res 3: 11. doi:10.1186/1743-8454-3-11. PubMed: 17020616.
20. Mellerup ET, Rafaelsen OJ (1981) Depression and cerebrospinal fluid citrate. Acta Psychiatr Scand 63: 57-60. doi:10.1111/j.1600-0447.1981.tb00708.x. PubMed: 7234465. (Pubitemid 11143250)
21. Kosicek M, Kirsch S, Bene R, Trkanjec Z, Titlic M et al. (2010) Nano-HPLC-MS analysis of phospholipids in cerebrospinal fluid of Alzheimer's disease patients-a pilot study. Anal Bioanal Chem 398: 2929-2937. doi:10.1007/s00216-010-4273-8. PubMed: 20953867.
22. Silverstone PH, McGrath BM, Kim H (2005) Bipolar disorder and myoinositol: a review of the magnetic resonance spectroscopy findings. Bipolar Disord 7: 1-10. doi:10.1111/j.1399-5618.2004.00174.x. PubMed: 15654927. (Pubitemid 40227831)
23. Wuolikainen A, Moritz T, Marklund SL, Antti H, Andersen PM (2011) Disease-related changes in the cerebrospinal fluid metabolome in amyotrophic lateral sclerosis detected by GC/TOFMS. PLOS ONE 6: e17947. doi:10.1371/journal. pone.0017947. PubMed: 21483737.
24. Blasco H, Corcia P, Moreau C, Veau S, Fournier C et al. (2010) 1H-NMR-based metabolomic profiling of CSF in early amyotrophic lateral sclerosis. PLOS ONE 5: e13223. doi:10.1371/journal.pone.0013223. PubMed: 20949041.
25. Wo?owicka L, Drobnik L, Tomaszkiewicz T (1975) Correlation between acid-base status, concentrations of lactate and of pyruvate in blood and cerebrospinal fluid in patients treated in an intensive care unit. Resuscitation 4: 33-38. doi:10.1016/0300-9572(75)90062-3. PubMed: 1188190.
26. Dekker LJ, Boogerd W, Stockhammer G, Dalebout JC, Siccama I et al. (2005) MALDI-TOF mass spectrometry analysis of cerebrospinal fluid tryptic peptide profiles to diagnose leptomeningeal metastases in patients with breast cancer. Mol Cell Proteomics 4: 1341-1349. doi:10.1074/mcp.M500081-MCP200. PubMed: 15970584. (Pubitemid 41448721)
27. Hutchesson A, Preece MA, Gray G, Green A (1997) Measurement of lactate in cerebrospinal fluid in investigation of inherited metabolic disease. Clin Chem 43: 158-161. PubMed: 8990239. (Pubitemid 27024407)
28. Zwingmann C, Butterworth R (2005) An update on the role of brain glutamine synthesis and its relation to cell-specific energy metabolism in the hyperammonemic brain: Further studies using NMR spectroscopy. Neurochem Int 47: 19-30. doi:10.1016/j.neuint.2005.04.003. PubMed: 15916833.
29. Gomez-Mancilla B, Marrer E, Kehren J, Kinnunen A, Imbert G et al. (2005) Central nervous system drug development: an integrative biomarker approach toward individualized medicine. NeuroRx 2: 683-695. doi:10.1602/neurorx.2.4.683. PubMed: 16489375. (Pubitemid 41393275)
30. Frank R, Hargreaves R (2003) Clinical biomarkers in drug discovery and development. Nat Rev Drug Discov 2: 566-580. doi:10.1038/nrd1130. PubMed: 12838269. (Pubitemid 37361748)
31. Hong L, Jiang W, Zheng W, Zeng S (2011) HPLC analysis of paraaminosalicylic acid and its metabolite in plasma, cerebrospinal fluid and brain tissues. J Pharm Biomed Anal 54: 1101-1109. doi:10.1016/j.jpba.2010.11. 031. PubMed: 21159459.
32. Dawidowicz AL, Kalitynski R (2003) HPLC investigation of free and bound propofol in human plasma and cerebrospinal fluid 17. Biomed Chromatogr. pp. 447-452. (Pubitemid 37407000)
33. Quinones MP, Kaddurah-Daouk R (2009) Metabolomics tools for identifying biomarkers for neuropsychiatric diseases. Neurobiol Dis 35: 165-176. doi:10.1016/j.nbd.2009.02.019. PubMed: 19303440.
34. Pugliese M, Carrasco JL, Andrade C, Mas E, Mascort J et al. (2005) Severe cognitive impairment correlates with higher cerebrospinal fluid levels of lactate and pyruvate in a canine model of senile dementia. Prog Neuropsychopharmacol Biol Psychiatry 29: 603-610. doi:10.1016/j.pnpbp.2005.01. 017. PubMed: 15866364. (Pubitemid 40603837)
35. Satoh H, Yamato O, Asano T, Yonemura M, Yamauchi T et al. (2007) Cerebrospinal fluid biomarkers showing neurodegeneration in dogs with GM1 gangliosidosis: possible use for assessment of a therapeutic regimen. Brain Res 1133: 200-208. doi:10.1016/j.brainres.2006.11.039. PubMed: 17196562. (Pubitemid 46123246)
36. Holt DE, Washabau RJ, Djali S, Dayrell-Hart B, Drobatz KJ et al. (2002) Cerebrospinal fluid glutamine, tryptophan, and tryptophan metabolite concentrations in dogs with portosystemic shunts. Am J Vet Res 63: 1167-1171. doi:10.2460/ajvr.2002.63.1167. PubMed: 12171172. (Pubitemid 35276903)
37. Sugi T, Fujishima M, Omae T (1975) Lactate and pyruvate concentrations, and acid-base balance of cerebrospinal fluid in experimentally induced intracerebral and subarachnoid hemorrhage in dogs. Stroke 6: 715-719. doi:10.1161/01.STR.6.6.715. PubMed: 822.
38. Iwabuchi T, Watanabe K, Kutsuzawa T, Ikeda K, Nakamura T (1973) Lactate in the cerebrospinal fluid and pressure-flow relationships in canine cerebral circulation. Stroke 4: 207-212. doi:10.1161/01.STR.4.2.207. PubMed: 4702308.
39. Witsberger TH, Levine JM, Fosgate GT, Slater MR, Kerwin SC et al. (2012) Associations between cerebrospinal fluid biomarkers and longterm neurologic outcome in dogs with acute intervertebral disk herniation. J Am Vet Med Assoc 240: 555-562. doi:10.2460/javma.240.5.555. PubMed: 22332624.
40. Ellenberger C, Mevissen M, Doherr M, Scholtysik G, Jaggy A (2004) Inhibitory and excitatory neurotransmitters in the cerebrospinal fluid of epileptic dogs. Am J Vet Res 65: 1108-1113. doi:10.2460/ajvr.2004.65.1108. PubMed: 15334845. (Pubitemid 39136633)
41. Butterworth J, Gregory CR, Aronson LR (1997) Selective alterations of cerebrospinal fluid amino acids in dogs with congenital portosystemic shunts. Metab Brain Dis 12: 299-306. doi:10.1023/A:1022378209979. PubMed: 9475503. (Pubitemid 28099329)
42. Ciurtin C, Nicolescu A, Stefan LI, Kovacs E, Smith ICP et al. (2007) Metabolic profiling of urine by 1H-NMR spectroscopy - A critical assessment of interpreting metabolite concentrations for normal and diabetes groups. Rev Chim (Bucharest) 58: 51-55.
43. Stefan LI, Nicolescu A, Popa S, Mota M, Kovacs E et al. (2010) 1H-NMR Urine Metabolic Profiling in Type 1 Diabetes Mellitus. Rev Roum Chim 55: 1033-1037.
44. Nicolescu A, Dolenko B, Bezabeh T, Stefan LI, Ciurtin C et al. (2011) Diagnosis of Type II Diabetes based on Non-glucose Regions of 1H NMR Spectra of Urine A metabonornic approach. Rev Chim (Bucharest) 62: 1150-1153.
45. Nicolescu A, Simionescu N, Ursu L, Deleanu C, Simionescu BC (2012) The effect of therapeutic doses of paracetamol and aspirin on the NMR profile of urine at 400 MHz. Rev Roum Chim 57: 653-658.
46. Lutz NW, Maillet S, Nicoli F, Viout P, Cozzone PJ (1998) Further assignment of resonances in H-1 NMR spectra of cerebrospinal fluid (CSF). FEBS Lett 425: 345-351. doi:10.1016/S0014-5793(98)00262-2. PubMed: 9559677. (Pubitemid 28178919)
47. Wishart DS, Knox C, Guo AC, Eisner R, Young N et al. (2009) HMDB: a knowledgebase for the human metabolome. Nucleic Acids Res 37: D603-D610. doi:10.1093/nar/gkn810. PubMed: 18953024.
48. Stoop MP, Coulier L, Rosenling T, Shi S, Smolinska AM et al. (2010) Quantitative proteomics and metabolomics analysis of normal human cerebrospinal fluid samples. Mol Cell Proteomics 9: 2063-2075. doi:10.1074/mcp.M110.000877. PubMed: 20811074.
49. Crews B, Wikoff WR, Patti GJ, Woo HK, Kalisiak E et al. (2009) Variability analysis of human plasma and cerebral spinal fluid reveals statistical significance of changes in mass spectrometry-based metabolomics data. Anal Chem 81: 8538-8544. doi:10.1021/ac9014947. PubMed: 19764780.
50. Salomon RM, Ripley B, Kennedy JS, Johnson B, Schmidt D et al. (2003) Diurnal variation of cerebrospinal fluid hypocretin-1 (Orexin-A) levels in control and depressed subjects. Biol Psychiatry 54: 96-104. doi:10.1016/S0006- 3223(02)01740-7. PubMed: 12873798. (Pubitemid 36859768)
51. Smith AR, Rossi-Fanelli F, Ziparo V, James JH, Perelle BA et al. (1978) Alterations in plasma and CSF amino acids, amines and metabolites in hepatic coma. Ann Surg 187: 343-350. doi:10.1097/00000658-197803000-00024. PubMed: 637594. (Pubitemid 8303274)
52. Aasly J, Gårseth M, Sonnewald U, Zwart JA, White LR et al. (1997) Cerebrospinal fluid lactate and glutamine are reduced in multiple sclerosis. Acta Neurol Scand 95: 9-12. doi:10.1111/j.1600-0404.1997.tb00060.x. PubMed: 9048978. (Pubitemid 27094774)
53. Maillet S, Vion-Dury J, Confort-Gouny S, Nicoli F, Lutz NW, et al. (1998) Experimental protocol for clinical analysis of cerebrospinal fluid by high resolution proton magnetic resonance spectroscopy. Brain Res Brain Res Protoc 3: 123-134 (Pubitemid 28527094)
54. Levine J, Panchalingam K, Rapoport A, Gershon S, McClure RJ et al. (2000) Increased cerebrospinal fluid glutamine levels in depressed patients. Biol Psychiatry 47: 586-593. doi:10.1016/S0006-3223(99)00284-X. PubMed: 10745050. (Pubitemid 30169251)
55. Li FY, Cuddon PA, Song J, Wood SL, Patterson JS et al. (2006) Canine spongiform leukoencephalomyelopathy is associated with a missense mutation in cytochrome b. Neurobiol Dis 21: 35-42. doi:10.1016/j.nbd.2005.06.009. PubMed: 16026996. (Pubitemid 41817303)
56. Levine J, Panchalingam K, McClure RJ, Gershon S, Pettegrew JW (2000) Stability of CSF metabolites measured by proton NMR. J Neural Transm 107: 843-848. doi:10.1007/s007020070064. PubMed: 11005549. (Pubitemid 30468271)
57. Toczyłowska B, Chalimoniuk M, Wodowska M, Mayzner-Zawadzk E (2006) Changes in concentration of cerebrospinal fluid components in patients with traumatic brain injury. Brain Res 1104: 183-189. doi:10.1016/j.brainres.2006.05. 057. PubMed: 16793028. (Pubitemid 44148521)
58. Benoist JF, Alberti C, Leclercq S, Rigal O, Jean-Louis R et al. (2003) Cerebrospinal fluid lactate and pyruvate concentrations and their ratio in children: Age-related reference intervals. Clin Chem 49: 487-494. doi:10.1373/49.3.487. PubMed: 12600962. (Pubitemid 36250210)
59. Subramanian A, Gupta A, Saxena S, Gupta A, Kumar R et al. (2005) Proton MR CSF analysis and a new software as predictors for the differentiation of meningitis in children. NMR Biomed 18: 213-225. doi:10.1002/nbm.944. PubMed: 15627241. (Pubitemid 40936441)
60. Commodari F, Arnold DL, Sanctuary BC, Shoubridge EA (1991) 1H NMR characterization of normal human cerebrospinal fluid and the detection of methylmalonic acid in a vitamin B12 deficient patient. NMR Biomed 4: 192-200. doi:10.1002/nbm.1940040407. PubMed: 1931558.
61. Tallaksen CME, Bøhmer T, Bell H (1992) Concentrations of the Water-Soluble Vitamins Thiamin, Ascorbic-Acid, and Folic-Acid in Serum and Cerebrospinal-Fluid of Healthy-Individuals. Am J Clin Nutr 56: 559-564. PubMed: 1503069.
62. Bayir H, Kagan VE, Tyurina YY, Tyurin V, Ruppel RA et al. (2002) Assessment of antioxidant reserves and oxidative stress in cerebrospinal fluid after severe traumatic brain injury in infants and children. Pediatr Res 51: 571-578. doi:10.1203/00006450-200205000-00005. PubMed: 11978879.